株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

連続血糖モニタリング(CGM)システム/装置市場規模、シェア、動向分析:コンポーネント別(トランスミッター、センサー、インスリンポンプ)、エンドユース別(病院、在宅医療)、セグメント予測(2018〜2024年)

Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024

発行 Grand View Research, Inc. 商品コード 682154
出版日 ページ情報 英文 55 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。
Back to Top
連続血糖モニタリング(CGM)システム/装置市場規模、シェア、動向分析:コンポーネント別(トランスミッター、センサー、インスリンポンプ)、エンドユース別(病院、在宅医療)、セグメント予測(2018〜2024年) Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024
出版日: 2018年07月16日 ページ情報: 英文 55 Pages
概要

世界の連続血糖モニタリング(CGM)システム/装置市場規模は2024年までに10億1,000万米ドルに達すると予測されています。糖尿病件数の増加、新規および最新糖尿病ケア装置の導入などが市場の成長を牽引する主な要因となっています。

当レポートでは、世界の連続血糖モニタリング(CGM)システム/装置市場について調査し、市場の現状と2024年までの成長予測、コンポーネント別、エンドユース別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
  • 業界動向分析
  • PESTLE分析
  • ポーターズファイブフォースモデル
  • 企業の市場シェア分析
  • 優先される主な機会

第4章 マーケティング製品別見通し

  • 収益シェア:製品別
  • トランスミッターとレシーバー
  • センサー
  • インスリンポンプ

第5章 エンドユーザー別見通し

  • 収益シェア:エンドユーザー別
  • 病院
  • 在宅ケア診断
  • その他

第6章 地域別見通し

  • 市場シェア:地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第7章 競合環境

  • Roche Diagnostics
  • Dexcom Inc.
  • Abbott Laboratories
  • Medtronic Inc.
  • Animas Corporation
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
図表

List of Tables

  • 1. Continuous Glucose Monitoring Devices - Industry Snapshot & Key Buying Criteria, 2013 - 2024
  • 2. Continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 3. Continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 4. Continuous glucose monitoring devices market, by region, 2013 - 2024 (USD Million)
  • 5. Continuous glucose monitoring devices - Key Market Driver Analysis
  • 6. Continuous glucose monitoring devices - Key Market Restraint Analysis
  • 7. North America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 8. U.S. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 9. U.S. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 10. Canada continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 11. Canada continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 12. Europe continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 13. Germany continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 14. Germany continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 15. U.K. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 16. U.K. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 17. Asia Pacific continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 18. China continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 19. China continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 20. India continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 21. India continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 22. Latin America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 23. Brazil continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 24. Brazil continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 25. Mexico continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 26. Mexico continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 27. MEA continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 28. South Africa continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 29. South Africa continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 30. Saudi Arabia continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 31. Saudi Arabia continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)

List of Figures

  • 1. Continuous glucose monitoring devices: Market segmentation
  • 2. Continuous glucose monitoring devices, 2013 - 2024 (USD Million)
  • 3. Continuous glucose monitoring devices market: Industry trend analysis
  • 4. Continuous glucose monitoring devices market: PESTEL analysis
  • 5. Continuous glucose monitoring devices market: Porter's analysis
  • 6. Continuous glucose monitoring devices company market share, 2015
  • 7. Key Opportunities Prioritized
  • 8. Continuous glucose monitoring devices market revenue share by product, 2016 & 2024
  • 9. Transmitters and receivers market revenue, 2013 to 2024 (USD Million)
  • 10. Sensors market revenue, 2013 to 2024 (USD Million)
  • 11. Insulin pumps market revenue, 2013 to 2024 (USD Million)
  • 12. Continuous glucose monitoring devices market revenue share end user, 2016 & 2024
  • 13. Hospital market revenue, 2013 to 2024 (USD Million)
  • 14. Homecare Diagnostics market revenue, 2013 to 2024 (USD Million)
  • 15. Diagnostic Centers market revenue, 2013 to 2024 (USD Million)
  • 16. Others market revenue, 2013 to 2024 (USD Million)
  • 17. Continuous glucose monitoring devices market share, by region, 2016 & 2024
目次
Product Code: 978-1-68038-875-6

The global continuous glucose monitoring (CGM) devices market size is expected to reach USD 1.01 billion by 2024, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 13.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.

These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of CGM devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward market growth.

Further key findings from the study suggest:

  • Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
  • CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
  • Transmitters and receivers was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
  • Insulin pumps are anticipated to witness the highest CAGR during the forecast period due to their ability to maintain optimal blood glucose levels
  • Asia Pacific is the leading regional market, with Japan, China, and India on the forefront
  • North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
  • The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain

Some of the key companies present in the market are: Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Continuous Glucose Monitoring Devices Market - Industry Summary and Key Buying Criteria, 2013 - 2024

Chapter 3. Continuous Glucose Monitoring Devices Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2013 - 2024
  • 3.3. Continuous Glucose Monitoring Devices: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing number of diabetes patients globally
      • 3.3.1.2. Easy and efficient monitoring of current glucose values
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High surge in the price and cost of treatment
  • 3.4. Continuous Glucose Monitoring Devices Market: Industry trend analysis
  • 3.5. Continuous Glucose Monitoring Devices Market: PESTEL Analysis
  • 3.6. Continuous Glucose Monitoring Devices Industry Analysis - Porter's Five Forces Model
  • 3.7. Continuous Glucose Monitoring Devices: Company market share analysis (%), 2015
  • 3.8. Key opportunities prioritized

Chapter 4. Continuous Glucose Marketing Product Outlook

  • 4.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by Product, 2016 & 2024
  • 4.2. Transmitters and Receivers
    • 4.2.1. Transmitters and receivers market revenue, by region, 2013 to 2024 (USD Million)
  • 4.3. Sensors
    • 4.3.1. Sensors market revenue, by region, 2013 to 2024 (USD Million)
  • 4.4. Insulin Pumps
    • 4.4.1. Insulin pumps market revenue, by region, 2013 to 2024 (USD Million)

Chapter 5. Continuous Glucose Monitoring end - user Outlook

  • 5.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by end - user, 2016 & 2024
  • 5.2. Hospital
    • 5.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
  • 5.3. Homecare Diagnostics
    • 5.3.1. Homecare diagnostics market revenue, by region, 2013 to 2024 (USD Million)
  • 5.4. Others
    • 5.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)

Chapter 6. Continuous Glucose Monitoring Regional Outlook

  • 6.1. Continuous Glucose Monitoring Market Share (%) Analysis, by Region, 2014 & 2024
  • 6.2. North America
    • 6.2.1. U.S.
      • 6.2.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.2.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.2.2. Canada
      • 6.2.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.2.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.3. Europe
    • 6.3.1. Germany
      • 6.3.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.3.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.3.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. China
      • 6.4.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.4.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.4.2. India
      • 6.4.2.1.continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.4.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.5. MEA
    • 6.5.1. South Africa
      • 6.5.1.1. continuous glucose monitoring devices market, by product application, 2013 - 2024 (USD Million)
      • 6.5.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.5.2. Saudi Arabia
      • 6.5.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.5.2.2. continuous glucose monitoring devices market, by end - user application, 2013 - 2024 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.6.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.6.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Roche Diagnostics
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. Dexcom Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Abbott Laboratories
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. Medtronic Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Animas Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6. Novo Nordisk
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. Ypsomed AG
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. GlySens Incorporated
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
Back to Top